Copper peptides prolong anagen while shortening telogen
Specifically, the FDA moved away from aggressive enforcement postures on several key peptides that had been in regulatory limbo: BPC-157 (Body Protection Compound): Removed from the "Category 2" substances list that had restricted its use in compounded medications TB-500 (Thymosin Beta-4 fragment): Similar de-prioritization of enforcement actions against compounding pharmacies MOTS-C : Continued research status maintained without new restrictions This doesn't mean these peptides are FDA-approved drugs
At present, the website clinicaltrials.gov lists several clinical trials that use suPAR plasma levels to guide therapy or assess therapeutic response, but there are, as yet no interventional trials to reduce suPAR plasma or tissue levels
Insomnia can have many causes, including anxiety, depression, trauma, chronic pain, sleep apnea, restless legs syndrome, circadian rhythm disruption, medications, alcohol use, hormone changes, and stress
(2015) 10:e0132421